Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020-March 2021).

COVID-19 Italy VOC 202012/01-B.1.1.7 lineage SARS-CoV-2 surveillance variants of concern

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
29 Apr 2021
Historique:
received: 29 03 2021
revised: 28 04 2021
accepted: 28 04 2021
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 11 5 2021
Statut: epublish

Résumé

Epidemiological and virological studies have revealed that SARS-CoV-2 variants of concern (VOCs) are emerging globally, including in Europe. The aim of this study was to evaluate the spread of B.1.1.7-lineage SARS-CoV-2 in southern Italy from December 2020-March 2021 through the detection of the S gene target failure (SGTF), which could be considered a robust proxy of VOC B.1.1.7. SGTF was assessed on 3075 samples from week 52/2020 to week 10/2021. A subset of positive samples identified in the Apulia region during the study period was subjected to whole-genome sequencing (WGS). A descriptive and statistical analysis of the demographic and clinical characteristics of cases according to SGTF status was performed. Overall, 20.2% of samples showed SGTF; 155 strains were confirmed as VOC 202012/01 by WGS. The proportion of SGTF-positive samples rapidly increased over time, reaching 69.2% in week 10/2021. SGTF-positive cases were more likely to be symptomatic and to result in hospitalization (

Identifiants

pubmed: 33947087
pii: ijerph18094766
doi: 10.3390/ijerph18094766
pmc: PMC8125211
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet. 2021 Feb 6;397(10273):469-470
pubmed: 33485462
Euro Surveill. 2021 Mar;26(10):
pubmed: 33706862
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478621
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
BMJ. 2020 Dec 16;371:m4857
pubmed: 33328153
Microbiol Resour Announc. 2021 Jan 28;10(4):
pubmed: 33509997
Cell Rep Med. 2021 Apr 18;:100264
pubmed: 33899031

Auteurs

Daniela Loconsole (D)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Francesca Centrone (F)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Caterina Morcavallo (C)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Silvia Campanella (S)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Anna Sallustio (A)

Hygiene Unit, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, 70124 Bari, Italy.

Marisa Accogli (M)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Francesca Fortunato (F)

Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

Antonio Parisi (A)

Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata, 71121 Foggia, Italy.

Maria Chironna (M)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH